DPX BRAF/CPA

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDPX BRAF/CPA
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicity
TargetsNot applicable
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWistar InstituteIMV Inc
China Registration ClassN/A

Develop Information

Active CompaniesWistar InstituteIMV Inc
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A